Annual Report

Immunovant, Inc. Filed 2026-05-20 Acc 0001764013-26-000064

Documents 1

2026-05-22 4 Chief Operating Officer sold 3,115 shares at an average $32.45 ($101,072)
2026-05-20 144 Sale of Securities
2026-05-20 10-K Annual Report
2026-05-20 8-K Results of operations
2026-05-20 4 Director sold 6,000 shares at $32.00 ($192,000)
2025-05-29 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading imvt-20260331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…